Literature DB >> 28826565

Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescents and young adults.

Elaine M Urbina1, Connie E McCoy2, Zhiqian Gao2, Philip R Khoury2, Amy S Shah2, Lawrence M Dolan2, Thomas R Kimball2.   

Abstract

BACKGROUND: In adults, dyslipidemia is associated with higher carotid thickness and arterial stiffness, predictors of cardiovascular events. In young subjects, lipid concentrations have not been consistently associated with vascular measures.
OBJECTIVE: The objective of the study was to compare nuclear magnetic resonance (NMR) measures of lipoprotein particle number (low-density lipoprotein [LDL] particle, low-density lipoprotein [HDL] particle, very low-density lipoprotein [VLDL] particle) and size (LDL size, HDL size, and VLDL size) to determine if they were associated with vascular measures more strongly than lipid concentrations (LDL cholesterol, HDL cholesterol, and triglyceride [TG]).
METHODS: We evaluated 214 lean (L), 228 obese (O), and 214 diabetic (T2DM) subjects aged 10 to 24 years (33% male and 39% Caucasian). Cardiovascular risk factors, vascular structure, and arterial stiffness were measured. General linear models were constructed including demographics, risk factors, and traditional or NMR lipid parameters. A composite vascular function score was developed as the outcome in receiver operator characteristic scores for determining which lipid parameter was superior in predicting vascular damage.
RESULTS: Risk factors worsened from L to O to T. However, LDL cholesterol was similar in O and T, whereas LDL size differentiated the 3 groups (T > O > L, P ≤ .0001). Models demonstrated the superiority of NMR values, which entered for all but 1 vascular outcome and explained more of the variance than traditional lipid concentrations. Receiver operator characteristic curves demonstrated that NMR values were superior in predicting vascular outcomes. Models stratified by race were similar but cutpoints predicting vascular outcomes differed by race for TG, TG/HDL, and VLDL.
CONCLUSION: Lipoprotein particle number and size are more strongly related to vascular structure and function than traditional lipid values. NMR lipid measures may be a better indicator of risk for target organ damage than traditional lipid measures in adolescents and young adults.
Copyright © 2017 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Carotid arteries; Dyslipidemia; Lipoproteins; Pediatrics

Mesh:

Substances:

Year:  2017        PMID: 28826565      PMCID: PMC5657457          DOI: 10.1016/j.jacl.2017.05.011

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  41 in total

1.  LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

Authors:  C Skoglund-Andersson; R Tang; M G Bond; U de Faire; A Hamsten; F Karpe
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

2.  Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.

Authors:  Salim S Virani; Lisa Pompeii; Andrew E Lincoln; Reginald E Dunn; Andrew M Tucker; Vijay Nambi; Khurram Nasir; Robert A Vogel; Jeffrey L Boone; Arthur J Roberts; Christie M Ballantyne
Journal:  Atherosclerosis       Date:  2012-04-03       Impact factor: 5.162

3.  Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus.

Authors:  Elaine M Urbina; Thomas R Kimball; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

4.  Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study.

Authors:  Wendy S Tzou; Pamela S Douglas; Sathanur R Srinivasan; Wei Chen; Gerald Berenson; James H Stein
Journal:  Ann Intern Med       Date:  2005-05-03       Impact factor: 25.391

5.  Managing to low-density lipoprotein particles compared with low-density lipoprotein cholesterol: a cost-effectiveness analysis.

Authors:  John A Rizzo; Peter J Mallow; Heidi C Waters; Gregory S Pokrywka
Journal:  J Clin Lipidol       Date:  2013-06-18       Impact factor: 4.766

6.  Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.

Authors:  T J Lyons; A J Jenkins; D Zheng; R L Klein; J D Otvos; Y Yu; D T Lackland; D McGee; M B McHenry; M Lopes-Virella; W T Garvey
Journal:  Diabet Med       Date:  2006-09       Impact factor: 4.359

7.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.

Authors:  James D Otvos; Samia Mora; Irina Shalaurova; Philip Greenland; Rachel H Mackey; David C Goff
Journal:  J Clin Lipidol       Date:  2011 Mar-Apr       Impact factor: 4.766

8.  The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.

Authors:  S S Soedamah-Muthu; H M Colhoun; M J Thomason; D J Betteridge; P N Durrington; G A Hitman; J H Fuller; K Julier; M I Mackness; H A W Neil
Journal:  Atherosclerosis       Date:  2003-04       Impact factor: 5.162

9.  Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

10.  Association of the auscultatory gap with vascular disease in hypertensive patients.

Authors:  M C Cavallini; M J Roman; S G Blank; R Pini; T G Pickering; R B Devereux
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391

View more
  8 in total

1.  Caregiving stress and burden associated with cardiometabolic risk in family caregivers of individuals with cancer.

Authors:  Lena J Lee; Youngmee Kim; Robert Shamburek; Alyson Ross; Li Yang; Margaret F Bevans
Journal:  Stress       Date:  2022-01       Impact factor: 3.340

2.  Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.

Authors:  Victoria Higgins; Shervin Asgari; Jill K Hamilton; Anna Wolska; Alan T Remaley; Bolette Hartmann; Jens J Holst; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 3.  Natural History of Atherosclerosis and Abdominal Aortic Intima-Media Thickness: Rationale, Evidence, and Best Practice for Detection of Atherosclerosis in the Young.

Authors:  Michael R Skilton; David S Celermajer; Erich Cosmi; Fatima Crispi; Samuel S Gidding; Olli T Raitakari; Elaine M Urbina
Journal:  J Clin Med       Date:  2019-08-12       Impact factor: 4.241

4.  Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks.

Authors:  Angeliki Makri; Anita Cheung; Ninet Sinaii; Alan T Remaley; Maureen Sampson; Meg Keil; Elena Belyavskaya; Charalampos Lyssikatos; Maria De La Luz Sierra; Constantine A Stratakis; Maya Lodish
Journal:  Pediatr Res       Date:  2019-05-21       Impact factor: 3.756

Review 5.  Dyslipidemia in Pediatric Type 2 Diabetes Mellitus.

Authors:  Bhuvana Sunil; Ambika P Ashraf
Journal:  Curr Diab Rep       Date:  2020-09-09       Impact factor: 4.810

6.  Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.

Authors:  Feifei Liu; Qi Jiang; Xuedong Sun; Yuzhen Huang; Zhenzhen Zhang; Ting Han; Yuhua Shi
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

7.  Postprandial dyslipidemia in insulin resistant states in adolescent populations.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  J Biomed Res       Date:  2020-01-30

8.  Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.

Authors:  Bárbara Fernández-Cidón; Beatriz Candás-Estébanez; Miriam Gil-Serret; Núria Amigó; Emili Corbella; M Ángeles Rodríguez-Sánchez; Ariadna Padró-Miquel; Carlos Brotons; Antonio Hernández-Mijares; Pilar Calmarza; Estibaliz Jarauta; Angel J Brea; Marta Mauri; Carlos Guijarro; Àlex Vila; Pedro Valdivielso; Xavier Corbella; Xavier Pintó
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.